Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €8.08 | €11.00 | 36.172% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.50 | €5.76 | 64.469% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.85 | €41.10 | 59.006% |
| Evolus Inc | 6 | 1 | 1 | 1 | €11.80 | €20.26 | 71.656% |
| Immunic Inc. | 6 | 3 | 1 | 2 | €1.23 | €5.48 | 345.313% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €7.20 | €8.75 | 21.528% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.50 | €7.00 | 100.000% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €149.55 | €173.22 | 15.826% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| Stoke Therapeutics Inc | 13 | 1 | 2 | 0 | €11.20 | €21.00 | 87.532% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.68 | €22.78 | 79.687% |
| Personalis Inc | 6 | 0 | 2 | 0 | €1.50 | €3.24 | 116.640% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €24.20 | €68.78 | 184.212% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.94 | €78.42 | 57.033% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.44 | €10.00 | 594.444% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.09 | €19.86 | 226.189% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €889.20 | €957.22 | 7.650% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.60 | €35.00 | -13.793% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |